eFFECTOR Therapeutics, Inc. Warrant
EFTRW
EFTRW was delisted on the 2nd of July, 2024.
12 hedge funds and large institutions have $355K invested in eFFECTOR Therapeutics, Inc. Warrant in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and 1 closing their positions.
22% more capital invested
Capital invested by funds: $290K → $355K (+$65K)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$20.5K |
| 2 |
SOA
Sea Otter Advisors
Miami,
Florida
|
-$3.2K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$101 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Aristeia Capital
Greenwich,
Connecticut
| $183K | -$20.5K | -159,746 | -11% |
|
2
Goldman Sachs
New York
| $85.2K | – | – | – |
|
|
WA
3
Whitebox Advisors
Minneapolis,
Minnesota
| $40.3K | – | – | – |
|
|
MI
4
MMCAP International
Grand Cayman,
Cayman Islands
| $19.7K | – | – | – |
|
|
PA
5
Parallel Advisors
San Francisco,
California
| $8.67K | – | – | – |
|
|
ICM
6
III Capital Management
Boca Raton,
Florida
| $5.75K | – | – | – |
|
|
TCM
7
Tenor Capital Management
New York
| $4.5K | – | – | – |
|
|
SOA
8
Sea Otter Advisors
Miami,
Florida
| $3.38K | -$3.2K | -25,000 | Closed |
|
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2.35K | +$2.15K | +16,794 | New |
|
|
WAM
10
Wolverine Asset Management
Chicago,
Illinois
| $1.33K | -$1K | -7,816 | -44% |
|
|
11
UBS Group
Zurich,
Switzerland
| $87 | -$101 | -790 | -55% |
|
|
PA
12
Pineridge Advisors
St. Charles,
Missouri
| $4 | – | – | – |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| $3 | – | – | – |
|
EFTRW Hedge Fund Activity: Q1 2024 in Review
12 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Warrant (EFTRW) for Q1 2024, worth a combined $355K — up 22% from $290K a quarter earlier.
Fund positioning in EFTRW was balanced in Q1 2024: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $2.15K. The largest seller was Aristeia Capital, cutting an estimated $20.5K.
- 12 institutional investors held eFFECTOR Therapeutics, Inc. Warrant (EFTRW) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $355K of eFFECTOR Therapeutics, Inc. Warrant stock for Q1 2024, up 22% quarter-over-quarter.
- 1 fund opened new eFFECTOR Therapeutics, Inc. Warrant positions in Q1 2024 and 1 closed out, a net change of 0 holders.
- The largest eFFECTOR Therapeutics, Inc. Warrant buyer in Q1 2024 was Susquehanna International Group, an estimated $2.15K added.
- The largest eFFECTOR Therapeutics, Inc. Warrant seller in Q1 2024 was Aristeia Capital, an estimated $20.5K sold.
Based on aggregated 13F filings for Q1 2024.